Amiodarone-induced lymphocyte toxicity and mitochondrial function

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 1, 1996, Pages 94-100

  Yasuda, Sally Usdin ^a,d   Sausville, Edward A ^a   Hutchins, James B ^b   Kennedy, Thomas ^c   Woosley, Raymond L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c McGuire Research Institute   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Adenine nucleotides; Amiodarone; Lactate dehydrogenase; Lymphocytes; Mitochondria; Toxicity

Indexed keywords

AMIODARONE; LACTATE DEHYDROGENASE; TETRAZOLIUM;

ARTICLE; CELL ULTRASTRUCTURE; DOSE RESPONSE; ELECTRON MICROSCOPY; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; LETHAL DOSE; LIVER TOXICITY; LUNG TOXICITY; LYMPHOCYTOTOXICITY; MITOCHONDRIAL RESPIRATION; PHOSPHATE METABOLISM; PRIORITY JOURNAL;

ADENOSINE; ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOCYTES; MITOCHONDRIA;

EID: 0029895134     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199607000-00015     Document Type: Article

References (47)

1. Rigas B, Rosenfeld LE, Barwick KW, et al. Amiodarone hepatotoxicity. Ann Intern Med 1986;104:348-51.
2. Mason JW. Amiodarone. N Engl J Med 1987;316:455-66.
3. Mechlis S, Lubin E, Laor J, Margaliot M, Strasberg B. Amiodarone-induced thyroid gland dysfunction. Am J Cardiol 1987;59:833-5.
4. Kudenchuk PJ, Pierson DJ, Greene HL, Graham EL, Sears GK, Trobaugh GB. Prospective evaluation of amiodarone pulmonary toxicity. Chest 1984;86:541-8.
5. Marchlinski FE, Gansler TS, Waxman HL, Josephson ME. Amiodarone pulmonary toxicity. Ann Intern Med 1982;97:839-45.
6. Rubin D, McAllister A, Sorbera C, Kay RH. Subacute pulmonary toxicity from amiodarone. NY State J Med 1991;91:403-5.
7. Hawthorne HR, Wood MA, Stambler BS, Damiano RJ, Ellenbogen KA. Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation. PACE 1993;16:2241-9.
8. Daniels JM, Brien JF, Massey TE. Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone. Toxicol Appl Pharmacol 1989;100:350-9.
9. Kennedy TP, Gordon GB, Paky A, et al. Amiodarone causes acute oxidant lung injury in ventilated and perfused rabbit lungs. J Cardiovasc Pharmacol 1988;12:23-36.
10. Martin WJ, Kachel DL, Vilen T, Natarajan V. Mechanism of phospholipidosis in amiodarone pulmonary toxicity. J Pharmacol Exp Ther 1989;251:272-8.
11. Beddows SA, Page SR, Taylor A, et al. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem Pharmacol 1989;38:4397-403.
12. Fromenty B, Letteron P, Fisch C, Berson A, Deschamps D, Pessayre D. Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Biochem Pharmacol 1993;46:421-32.
13. Somani P, Bandyopadhyay S, Klaunig JE, Gross SA. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes. Hepatology 1990;11:81-92.
14. Gross SA, Bandyopadhyay S, Klaunig JE, Somani P. Amiodarone and desethylamiodarone toxicity in isolated hepatocytes in culture (42844). Proc Soc Exp Biol Med 1989;190:163-9.
15. Dzimiri N, Almotrefi AA. Actions of amiodarone on mitochondrial ATPase and lactate dehydrogenase activities in guinea pig heart preparations. Eur J Pharmacol 1993;242:113-8.
16. Reasor MJ, Ogle CL, Walker ER, Kacew S. Amiodarone-induced phospholipidosis in rat alveolar macrophages. Am Rev Respir Dis 1988;137:510-8.
17. Martin WJ, Standing JE. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects. J Pharmacol Exp Ther 1988;244:774-9.
18. Hostetler KY, Reasor MJ, Walker ER, Yazaki PJ, Frazee BW. Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats. Biochim Biophys Acta 1986;875:400-5.
19. Fromenty B, Fisch C, Berson A, Letteron P, Larrey D, Pessayre D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 1990;255:1377-84.
20. Spielberg SP. Acetaminophen toxicity in human lymphocytes in vitro. J Pharmacol Exp Ther 1980;213:395-8.
21. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. J Clin Invest 1988;82:1-7.
22. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
23. Gonzales LW, Geel SE. Thin-layer chromatography of brain adenine nucleoside and nucleotides and determination of ATP specific activity. Anal Biochem 1975;63:400-13.
24. Decker T, Lohmann-Matthes M. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;15:61-9.
25. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;232:E97-102.
26. Slater TF, Sawyer B, Sträuli U. Studies on succinate-tetrazolium reductase systems. Biochim Biophys Acta 1963; 77:383-93.
27. Bandyopadhyay S, Somani P. A comparison of plasma, white blood cell, red blood cell, and tissue distribution of amiodarone and desethylamiodarone in anesthetized dogs. J Cardiovasc Pharmacol 1987;10:379-88.
28. Neyroz P, Bonati M. In vitro amiodarone protein binding and its interaction with warfarin. Experientia 1985;41:361-3.
29. Nokin P, Jungbluth L, Mouton J. Protective effects of amiodarone pretreatment on mitochondrial function and high energy phosphates in ischaemic rat heart. Mol Cell Cardiol 1987;19:603-14.
30. Chatelain P, Laruel R, Vic P, Brotelle R. Differential effects of amiodarone and propranolol on lipid dynamics and enzymatic activities in cardiac sarcolemmal membranes. Biochem Pharmacol 1989;38:1231-9.
31. Herbette LG, Trumbore M, Chester DW, Katz AM. Possible molecular basis for the pharmacokinetics and pharmaco-dynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone. J Mol Cell Cardiol 1988;20:373-8.
32. Sautereau A, Tournaire C, Suares M, Tocanne J, Paillous JF. Interactions of amiodarone with model membranes and amiodarone-photoinduced peroxidation of lipids. Biochem Pharmacol 1992;43:2559-66.
33. Chatelain P, Ferreira J, Laruel R, Ruysschaert JM. Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization study. Biochem Pharmacol 1986;35:3007-13.
34. Chatelain P, Brotelle R, Laruel R. Decrease in lipid mobility in rat erythrocyte membrane after amiodarone chronic treatment. Biochem Pharmacol 1987;36:1564-5.
35. + ATPase activity in rat-brain synaptic membranes. Biochem Biophys Res Commun 1985; 129:148-54.
36. Bhakdi S. Tranum-Jensen J. Damage to mammalian cells by proteins that form transmembrane pores. Rev Physiol Biochem Pharmacol 1987;107:147-223.
37. Bernheimer AW, Rudy B. Interactions between membranes and cytolytic peptides. Biochim Biophys Acta 1986;864:123-41.
38. Murphy E, LeFurgey A, Lieberman M. Biochemical and structural changes in cultured heart cells induced by metabolic inhibition. Am J Physiol 1987;253:C700-6.
39. Beavis AD. On the inhibition of the mitochondrial inner membrane anion uniporter by cationic amphiphiles and other drugs. J Biol Chem 1989;264:1508-15.
40. Adams PC, Sloan P, Morley AR, Holt DW. Peripheral neutrophil inclusions in amiodarone treated patients. Br J Clin Pharmacol 1986;22:736-8.
41. Dake MD, Madison JM, Montgomery CK, et al. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Am J Med 1985;78:506-12.
42. Shaikh NA, Downar E, Butany J. Amiodarone - an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine. Mol Cell Biochem 1987;76:163-72.
43. Dean PJ, Groshart KD, Porterfield JG, Iansmith DH, Golden EB. Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases. Am J Clin Pathol 1987;87:7-13.
44. Kennedy JI, Meyers JL, Plumb VJ, Fulmer JD. Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 1987;147:50-5.
45. Rakita L, Sobol SM, Mostow N, Vrobel T. Amiodarone pulmonary toxicity. Am Heart J 1983;106:906-16.
46. Anastasiou NMI, Anderson JL, Nanas JN, et al. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrythmias. Can J Cardiol 1986;2:138-45.
47. Magro SA, Lawrence EC, Wheeler SH, Krafchek J, Lin HT, Wyndham CRC. Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests. J Am Coll Cardiol 1988;12:781-8.